Dear Editor: Many antidepressants, either alone or in combination, can induce mania. Mirtazapine is a new noradrenergic and specific serotinergic antidepressant that has been associated with mania when used to augment fluoxetine (1) and with hypomania when combined with sertraline (2). Bhanji and others have recently proposed a "norepinephrine syndrome" of dysphoric mania that is based on mirtazapine's mechanism of action and a constellation of symptoms it likely caused when prescribed at high dosages (3) . We report the case of a young woman who went on a shopping spree after mirtazapine was added to paroxetine that was unsuccessful in treating her depression.
Case Report
The patient is a mother of 3, aged 35 years, with a positive family history of unipolar depression. Seven years earlier, she had been diagnosed with postpartum depression that was successfully treated with paroxetine. After stopping the paroxetine, she remained well until recently, when she presented to her family physician with complaints of fatigue, decreased libido, loss of interest, bouts of tearfulness, and panic attacks. Her doctor started her on paroxetine 10 mg daily and subsequently referred her to the local psychiatrist, who confirmed the diagnosis of a major depressive illness and increased her paroxetine gradually to 50 mg daily. Despite the above regimen, she continued to suffer from depression, except for rare good days when she was able to do some of her housework. To relieve the depression, bupropion, olanzapine, and L-tryptophan were separately added to the paroxetine, but with little success. After stopping the above 3 agents because they failed to boost the antidepressant effect of paroxetine, her psychiatrist added mirtazapine to her treatment. The dosage was gradually increased to 45 mg daily, and she took the combination for 8 weeks. Around this time, the patient was referred to the Mood Disorder Service for consultation. She reported that she had become irritable and impulsive. She described herself as easily "snapping" at people. Her energy had increased and she had started binge eating for the first time. Most dramatically, she began to make large purchases; for example, she bought 10 T-shirts and 5 pairs of shorts for her children, 5 pairs of pants and 8 pairs of shorts for herself, and magnifying glasses for many of the neighbourhood children. Her husband had to return all these items.
Mirtazapine-induced hypomania was recognized, the mirtazapine was discontinued, and the shopping sprees ceased soon thereafter. The remaining hypomanic symptoms also subsided later. However, the patient experienced depression. Her mood has stabilized with the addition of lithium carbonate.
Conclusion
The sudden episode of excessive and inappropriate spending resolved promptly when the offending agent, mirtazapine, was discontinued. We believe this is the first case of a shopping spree that was precipitated by the addition of mirtazapine to paroxetine when the latter failed to treat depressive symptoms.
Eric Prost, MD, Gaby Abraham, MD, FRCPC Kingston, Ontario

Age at Onset of Bipolar II Disorder
Dear Editor: Recently, 3 subgroups of bipolar I disorder (BD I), distinguished by different ages at onset, were found (1). Bipolar II disorder (BD II) has been found (according to Kolmogorov-Smirnov test) to have an age-at-onset distribution similar to that of BD I (2). Nevertheless, family studies (an important diagnostic validator) also support a distinction between the 2 disorders (3). The aim of the study reported here was to test whether BD II has 3 age-at-onset subgroups, as reported for BD I.
The study setting, patients, and interview methods are reported in detail elsewhere (4). The study setting was a private practice that has for many years studied BD II (see Benazzi F on PubMed/Medline). The study sample comprised 320 consecutively presenting outpatients (mean age of 41.6 years, SD 13.4) with BD II, 50.2% of whom had a family history of BD, and 68.4% of whom were women. Age at onset of the first major depressive episode (MDE) was assessed with the Structured Clinical Interview for DSM-IV-Clinician Version (5), often supplemented by interviews of family members or close friends.
With regard to onset-age of the first MDE, the mean (SD) age was 22.8 years (10.6), the median age was 20 years, and the age range was 4 to 67 years. Histogram and kernel density estimates were employed to study distribution of age at onset. A histogram results in disproportional representation of density at the centre and in the tails of the distribution, whereas kernel estimators are nonparametric histogram smoothers revealing multimodality. A histogram provides accurate pictures of categorical variables; univariate kernel density estimate is better to represent continuous variables (STATA 7 statistical software; 6). For this sample of patients with BD II, both histogram and kernel density estimate showed 3 age-at-onset subgroups: around age 19 years, around age 27 years, and around age 35 to 40 years (figures available on request from the author). Onset before age 20 years was present in 45.0% (144/320), onset between age 19 and 35 years in 42.8% (137/320), and onset after age 35 years in 12.2% (39/320).
Discussion
The similar results achieved from 2 different statistical approaches compared with the Bellivier and others study support the validity of these findings. Age-at-onset distribution in BD II was found to be similar to that in BD I, as reported by Bellivier and others (1). Because onset is an important diagnostic validator (2,7,8), finding 3 similar age-at-onset subgroups in BD I and BD II supports the hypothesis of a closer link between BD I and BD II. When more advanced statistical methods are used, the findings do not replicate the bimodality of onset that Kraepelin describes for manic-depressive insanity (8).
